Ansell’s shares surged 18.5% following a fiscal year '26 report that delivered top-line growth and margin expansion fueled by strong volume momentum, particularly in the U.S. and strategic segments like Cleanroom. The market rewarded clear evidence of pricing power offsetting tariff and geopolitical headwinds, driving a significant beat relative to expectations.
- Net sales grew 5.7% adjusted for the year, accelerating to 9.2% in the second half as volumes rebounded.
- Strong performance in Healthcare drove an EBIT margin increase from 12.8% to 14.3%, with Cleanroom business growing 10%.
- Industrial segment EBIT margin expanded to 18% (up from 17.3%) supported by 7% H2 Mechanical growth and U.S. aerospace/defense verticals.
- Successfully offset U.S. tariffs and Middle East supply chain disruptions through sourcing optimization and decisive pricing actions, preserving margin expansion.
- Cash conversion improved substantially to 113% from 91% last year, enabling a 35.7% dividend hike amid a strong balance sheet.
Community Discussion